Insider · CIK 0002065621
Sandra Isabelle Barros Alves
Files at RPTX (Repare Therapeutics Inc.). First filing -, latest -.
In brief
Sandra Isabelle Barros Alves files SEC Form 4 as officer at RPTX (Repare Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sandra Isabelle Barros Alves has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Common Shares | -31,622 | - | - | 0 | Jan 28, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -26,000 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Jan 28, 2026 | RPTX Repare Therapeutics Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -24,500 | $0.00 | $0 | 0 | Jan 28, 2026 |
| Apr 2, 2025 | RPTX Repare Therapeutics Inc. | AGrant or award Common Shares | +4,100 | $0.00 | $0 | 29,622 | Apr 29, 2025 |
| Apr 2, 2025 | RPTX Repare Therapeutics Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +24,500 | $0.00 | $0 | 24,500 | Apr 29, 2025 |
Questions about Sandra Isabelle Barros Alves
Answered from the filings on this page, as of the latest one.
Is Sandra Isabelle Barros Alves buying or selling?
Sandra Isabelle Barros Alves has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sandra Isabelle Barros Alves's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sandra Isabelle Barros Alves has 0.
Where does Sandra Isabelle Barros Alves file Form 4?
Sandra Isabelle Barros Alves has filed Form 4 at RPTX (Repare Therapeutics Inc.) as SVP, Finance and CAO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.